Indication
Non-cystic Fibrosis Bronchiectasis
8 clinical trials
9 products
Clinical trial
A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Exploratory Efficacy of Nebulized CSL787 in Healthy Subjects and Subjects With Non-Cystic Fibrosis Bronchiectasis (NCFB)Status: Completed, Estimated PCD: 2023-03-12
Product
PlaceboProduct
CSL787Product
ControlClinical trial
Airway Clearance Therapy With Simeox Technology in Non-Cystic Fibrosis Bronchiectasis Patients With Chronic Mucus Hypersecretion - A Multicenter Randomized Controlled Trial Pilot StudyStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ARINA-1 in Adult Participants With Non-CF Bronchiectasis (NCFBE) With Excess Mucus and CoughStatus: Completed, Estimated PCD: 2024-01-11
Product
ARINA-1Clinical trial
A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 52 Week, Phase III Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients With Non-Cystic Fibrosis Bronchiectasis (MAHALE)Status: Active (not recruiting), Estimated PCD: 2024-05-15
Product
BenralizumabProduct
AP-PA02Clinical trial
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 Multi-Phage Therapeutic in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa InfectionStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Effect of Hypertonic Saline on Mucociliary Clearance in Non-CF BronchiectasisStatus: Recruiting, Estimated PCD: 2025-06-01
Product
7% Hypertonic SalineClinical trial
Anti-inflammatory Effects of Roflumilast Treatment for 12 Weeks in Stable-state Non-cystic Fibrosis BronchiectasisStatus: Recruiting, Estimated PCD: 2024-06-30
Product
RoflumilastClinical trial
Evaluating Trikafta for the Treatment of Patients With Non-cystic Fibrosis Bronchiectasis (NCFBE)Status: Recruiting, Estimated PCD: 2024-06-01
Product
Trikafta